We report a case of Pseudomonas stutzeri septicaemia with purpura and bullae formation on the lower limbs, progressing to full thickness skin loss. The illness occurred on a background of corticosteroid therapy for chronic airflow limitation, and was associated with an occult colonic diverticulum perforation. To our knowledge the association of P.stutzeri septicaemia with these skin changes has not previously been described. The occurrence and pathogenicity of P.stutzeri is discussed.
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CASE REPORT
A 69-year-old white Caucasian male was admitted with a two-day history of painful swelling of his ankles and feet and pain in both calves. He also described some central chest pain occurring on walking on the day of admission.
These symptoms had occurred within a day of discharge from another hospital, where he had been admitted for a period of two weeks with worsening breathlessness. His dyspnoea had improved with treatment which had included 50mg/day of prednisolone, and amoxycillin/potassium clavulanate combination. He had suffered from chronic airflow limitation for about two years, diagnosed as predominantly asthma. He also had ischaemic heart disease on a background of hypercholesterolaemia, with a myocardial infarction and subsequent coronary artery bypass grafting five years earlier. He had no angina following his bypass grafts and remained in reasonable health until near the time of this admission.
At admission he was noted to be in atrial fibrillation with a ventricular rate of 160 to 190 beats/ minute. He was normotensive and apyrexial, but there was decreased air entry at the left base and chest radiograph confirmed left lower lobe consolidation. Abdominal examination was unremarkable. Examination of the legs revealed bilateral pitting oedema with a purpuric rash on both calves. Both calves were also noted to be exquisitely tender on palpation. Investigations at this stage revealed urea 15.2 mmol/l and creatinine 133 µmol/l, with liver function tests and cardiac enzymes within normal limits. Blood gases showed hypoxaemia (P a O 2 71 mmHg on air). Full blood count showed WCC 4.4 x 10 9 /l (neutrophils 4.18 x 10 9 /l, lymphocytes 0.14 x 10 9 /l, monocytes 0.07 x 10 9 /l), platelets 131 x 10 9 /l. Coagulation profile was normal. Sputum culture subsequently showed no growth.
Although an initial diagnosis of deep vein thrombosis with pulmonary embolism was made and the patient commenced on intravenous heparin, bilateral lower limb colour Doppler studies did not identify deep vein thrombosis. Technetium ventilation/perfusion lung scan showed no definite features to support pulmonary embolus, but did show widespread abnormalities of ventilation and perfusion in keeping with moderately severe chronic airflow limitation. The unusual rash was also not in keeping with deep vein thrombosis. The patient was commenced on cefotaxime and erythromycin in view of the left lower lobe changes.
The patient's condition continued to deteriorate such that by twenty-four hours he became hypotensive, anuric and encephalopathic. His WCC had fallen to 1.1 x 10 9 /l. He was transferred to the intensive care unit where he was intubated and ventilated, resuscitated with fluids and inotropes, and commenced on continuous venovenous haemodiafiltration (CVVHD). Steroid cover (hydrocortisone 100 mg six-hourly, gradually reducing) and systemic heparinization were continued. Examination prior to intubation showed a temperature of 36°C, no lymphadenopathy, normal fundi and an absence of focal neurological signs. He had persistent signs of consolidation at the left lung base. Atrial fibrillation was partially controlled with a ventricular rate of 120 beats/minute. Abdominal examination was unchanged. The rash on the legs had progressed rapidly to become a severe purpuric rash extending from the thighs to the feet with extensive formation of bullae which burst readily.
Investigations at this stage showed: WCC had increased to 8.2 x 10 9 /l (93% neutrophils), thrombocytopenia (platelets 67 x 10 9 /l, heparin-induced platelet aggregation test negative), creatinine kinase 239 IU/l (MB fraction and index not elevated), aspartate aminotransferase 93 IU/l, erythrocyte sedimentation rate 108mm/h. Auto-antibody screen including anti-neutrophil cytoplasmic antibody were negative. Immunoglobulins showed a moderately decreased IgG (3.7 g/l), with IgA and IgM within the reference range. Cryoglobulins were not detected. A transoe-sophageal echocardiograph revealed severe global impairment of left ventricular function, normal valves, and probable apical mural thrombus.
The antibiotic cover was broadened whilst awaiting cultures. An oxidase positive Gram-negative rod was isolated from two aerobic blood culture bottles, fluid from two separate blisters on the legs, and from biopsies of involved skin from three separate areas. The organism was identified as Pseudomonas stutzeri. This was treated with ceftazidime 2 g eight-hourly and tobramycin 240 mg daily (subject to acceptable measured trough levels), in keeping with the tested sensitivities of the organism.
Over the next few days the patient's condition improved, inotropes were weaned with satisfactory blood gases while ventilated with FiO 2 0.5. The abdomen remained soft with active bowel sounds, and the patient was absorbing nasogastric feed. He remained anuric on CVVHD. The rash on the legs, however, progressed to full thickness skin loss, estimated at 5% of total body surface area. Debridement and grafting was delayed because of concerns regarding continuing sepsis.
On day 6 of intensive care, increasing abdominal distension was noted, and a radiograph showed dilated loops of small bowel and free gas under the diaphragm. At laparotomy a perforated sigmoid diverticulum was found, with a partially sealed-off collection in the pelvis of 200ml of faeculent fluid. This was cultured and grew mixed enteral flora. Copious fibrinous exudate was noted indicating that the perforation was several days old. A Hartmann's procedure was performed. Metronidazole was added to the antibiotic regimen. A repeat laparotomy two days later showed a clean peritoneum, with clear peritoneal fluid.
Following the second laparotomy the patient's condition remained stable, and debridement and partial split skin grafting to the legs was performed six days later. At day 20 of intensive care there was, however, another acute deterioration, with recurrence of abdominal distension. A further laparotomy was performed which revealed infarction and necrosis of most of the small bowel in addition to areas of the transverse colon. It was felt to be surgically untreatable, and the patient was returned to the intensive care unit for palliative care.
DISCUSSION
Pseudomonas stutzeri is an uncommon clinical isolate. It was identified as an oxidase-positive Gramnegative rod forming typical dry wrinkled colonies on horse blood agar after overnight incubation. Identification was confirmed with 99% or greater probability by Vitek Automicrobic systems (bioMerieux) GNI (biocode 3010700010) and NFC (biocode 2023456340) cards, api 20 NE (bioMerieux; biocode 1044654), supported by demonstration of nitrogen gas production from nitrates, growth on MacConkey agar at 42°C, growth in 6.5% NaCl broth, and a negative test for arginine dihydrolase. The organism tested susceptible to gentamicin, tobramycin, imipenem, ciprofloxacin and aztreonam using the Vitek Automicrobic systems (bioMerieux) GNS-F5 and GNS-MM cards with results confirmed by standard replicator agar dilution break point testing on Isosensitest agar (Oxoid CM471). Ceftazidime susceptibility was determined by agar dilution alone.
CASE REPORT
A review 1 by the clinical microbiology laboratory of the University Hospital, Lexington, Kentucky, U.S.A., identified 36 isolates of P.stutzeri over a 16year period ending May 1993. In only three of these patients was the organism considered to be a pathogen, and in only one case was the organism isolated in pure culture. Similarly, a 19-year review ending in 1984 of Gram-negative nonfermentative bacteria submitted to the National Collection of Type Cultures in the United Kingdom, identified only 2.4% of the 4840 isolates as P.stutzeri 2 .
P.stutzeri is an environmental organism found in sewage and soil, and is generally considered to be of low pathogenicity. It can survive in the environment and has been identified in dialysis fluid causing bacteraemia in patients undergoing haemodialysis 3 . It has also been described as responsible for an outbreak of pseudobacteraemia due to contaminated aqueous green soap 4 . Serious infections with P.stutzeri are rare but have included prosthetic valve endocarditis 5 , pneumonia 6 , osteomyelitis 7 and septicaemia 8 . In many of these reports the patients had serious underlying pathology which predisposed them to infection. It has also been described as occasionally responsible for peritonitis in association with continuous ambulatory peritoneal dialysis [9] [10] [11] .
We have reviewed our own laboratory's isolation of P.stutzeri. Over a five-year period to December 1995 there were 19 isolates from 15 patients. Thirteen patients did not have disease attributable to P.stutzeri, and/or the organism was isolated from mixed cultures, or from fluid enrichment media only and not from direct sample and therefore unlikely to be significant. The two remaining cases in which P.stutzeri could have represented a significant pathogen were a 56-year-old woman with pneumonia in which it was isolated in pure culture from bronchoalveolar lavage, and a 46-year-old woman on continuous ambulatory peritoneal dialysis from whom peritoneal fluid grew P.stutzeri after a breakdown in aseptic technique.
In the case we report the patient was predisposed to infection by relatively high dose prednisolone. The primary focus of the P.stutzeri remains unknown, it was not isolated from the peritoneal fluid or sputum. It is possible that the septicaemic illness was due to the perforated diverticulum. The absence of abdominal signs consequent on steroid therapy is well described 12 , and probably led to delay in the diagnosis of the perforated viscus. A respiratory source remains possible in this case as P.stutzeri has been described as a cause of community-acquired pneumonia 6 . The skin changes were likely to be due to invasion of the skin by P.stutzeri (from haematogenous spread) as the organism was readily recovered from the fluid of the bullae, and from multiple skin biopsies.
Members of the genus Pseudomonas, usually P.aeruginosa, not uncommonly cause skin lesions. The dermatological manifestations of P.aeruginosa include erythema gangrenosum, subcutaneous nodules, vesicular lesions, gangrenous cellulitis, small papules and grouped petechiae. The most characteristic lesion caused by P.aeruginosa is ecthyma gangrenosum, a lesion which is caused by bacterial invasion of the skin 13 .
In our case P.stutzeri infection was controlled by the antibiotic therapy of tobramycin and ceftazidime but, unfortunately, further late complications led to the death of the patient.
